ESLA
Price
$1.59
Change
+$0.07 (+4.61%)
Updated
Dec 24 closing price
Capitalization
60.05M
Intraday BUY SELL Signals
TERN
Price
$42.38
Change
+$0.85 (+2.05%)
Updated
Dec 24 closing price
Capitalization
4.61B
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ESLA vs TERN

Header iconESLA vs TERN Comparison
Open Charts ESLA vs TERNBanner chart's image
Estrella Immunopharma
Price$1.59
Change+$0.07 (+4.61%)
Volume$11.22K
Capitalization60.05M
Terns Pharmaceuticals
Price$42.38
Change+$0.85 (+2.05%)
Volume$1.36M
Capitalization4.61B
ESLA vs TERN Comparison Chart in %
ESLA
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ESLA vs. TERN commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLA is a Hold and TERN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ESLA: $1.59 vs. TERN: $42.38)
Brand notoriety: ESLA and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ESLA: 4% vs. TERN: 29%
Market capitalization -- ESLA: $60.05M vs. TERN: $4.61B
ESLA [@Biotechnology] is valued at $60.05M. TERN’s [@Biotechnology] market capitalization is $4.61B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLA’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • ESLA’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, both ESLA and TERN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLA’s TA Score shows that 2 TA indicator(s) are bullish while TERN’s TA Score has 3 bullish TA indicator(s).

  • ESLA’s TA Score: 2 bullish, 6 bearish.
  • TERN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, TERN is a better buy in the short-term than ESLA.

Price Growth

ESLA (@Biotechnology) experienced а +1.92% price change this week, while TERN (@Biotechnology) price change was +0.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

TERN is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($4.61B) has a higher market cap than ESLA($60M). TERN YTD gains are higher at: 664.982 vs. ESLA (32.500). ESLA has higher annual earnings (EBITDA): -8.82M vs. TERN (-107.87M). TERN has more cash in the bank: 296M vs. ESLA (1.63M). ESLA (0) and TERN (0) have equivalent revenues.
ESLATERNESLA / TERN
Capitalization60M4.61B1%
EBITDA-8.82M-107.87M8%
Gain YTD32.500664.9825%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.63M296M1%
Total DebtN/A1.03M-
TECHNICAL ANALYSIS
Technical Analysis
ESLATERN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
52%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
46%
Bullish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ESLA
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MYRUF0.26N/A
+0.98%
Myriad Uranium Corp.
AGRPF8.11N/A
N/A
Absa Group Ltd.
CTRGF0.82N/A
N/A
Country Garden Svcs Hldgs Co Ltd.
MHGUP8.00N/A
N/A
Meritage Hospitality Group, Inc.
GWLL2.95N/A
N/A
GOLDENWELL BIOTECH INC.

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and PRLD have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and PRLD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+4.61%
PRLD - ESLA
24%
Poorly correlated
+1.83%
TERN - ESLA
24%
Poorly correlated
+2.05%
CYTOF - ESLA
23%
Poorly correlated
+6.25%
FATE - ESLA
23%
Poorly correlated
+3.40%
CMND - ESLA
23%
Poorly correlated
-5.76%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with ELVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
+2.05%
ELVN - TERN
42%
Loosely correlated
+1.21%
GPCR - TERN
41%
Loosely correlated
-2.24%
WVE - TERN
40%
Loosely correlated
+4.41%
MLTX - TERN
40%
Loosely correlated
+0.95%
STOK - TERN
40%
Loosely correlated
+0.97%
More